Endometrial Cancer

Adjuvant CRT Feasible for High-risk Endometrial Cancer

By

Adjuvant chemotherapy administered during and after radiotherapy is feasible for the treatment of patients with high-risk endometrial cancer despite an increased risk of toxicities compared with radiotherapy alone.

Telephone Follow-Up Effective for Stage I Endometrial Cancer

Telephone Follow-Up Effective for Stage I Endometrial Cancer

Nurse-based telephone follow-up was as effective as traditional hospital based follow-up for for stage I endometrial cancer.

Endometrial Cancer: Minimally Invasive vs Abdominal Hysterectomy

Endometrial Cancer: Minimally Invasive vs Abdominal Hysterectomy

By

Minimally invasive hysterectomy does not appear to compromise long-term survival compared with abdominal hysterectomy.

Combination Estrogen/Continuous Progestin Reduces Postmenopausal Risk of Endometrial Cancer

Combination Estrogen/Continuous Progestin Reduces Postmenopausal Risk of Endometrial Cancer

By

Adding continuous progestin to estrogen lowers the risk of endometrial cancer in postmenopausal women, according to a new study.

Weight-Loss Surgery Offers Dramatic Cancer Prevention Benefits

Weight-Loss Surgery Offers Dramatic Cancer Prevention Benefits

By

Bariatric surgery slashed the weight of obese women who are most at risk for cancer by one-third, produced a mean weight loss of more than 100 pounds, and eliminated precancerous uterine growths. It also improved physical quality of life, improved insulin levels and glucose use, and altered the composition of gut bacteria.

Non-Hispanic black women less likely to survive endometrial cancer than other races and ethnicities

By

Non-Hispanic black women with endometrial cancer display worse outcomes when compared to women in other racial/ethnic groups diagnosed with the same subtype of endometrial cancer.

Incidence of endometrial cancer increasing across multiple racial groups

Incidence of endometrial cancer increasing across multiple racial groups

Non-Hispanic black women have higher endometrial cancer incidence and lower survival across all stages and subtypes.

Birth control pill has lasting protective effects against endometrial cancer

Birth control pill has lasting protective effects against endometrial cancer

Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.

Oral contraceptives associated with endometrial cancer protection

Oral contraceptives associated with endometrial cancer protection

Use of oral contraceptives, even short-term, offers significant long-term protection against endometrial cancer and the protective effect seems to linger for decades after contraceptive is discontinued.

Extended-Field IMRT Does Not Increase Risk of Duodenal Toxicity

By

Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.

Link between Lynch syndrome, hormonal influences, and risk of endometrial cancer

Link between Lynch syndrome, hormonal influences, and risk of endometrial cancer

Researchers have found an association between the risk of endometrial cancer and the age of first menstrual cycle, having given birth, and hormonal contraceptive use for women with Lynch syndrome.

ASTRO guidelines for endometrial cancer endorsed by ASCO

ASTRO guidelines for endometrial cancer endorsed by ASCO

Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.

Robotic surgery safe for morbidly obese patients with endometrial cancer

Robotic surgery safe for morbidly obese patients with endometrial cancer

Use of robotic surgery showed no differences in blood loss, complication rates, or survival between morbidly obese and lower-weight patients.

Nut consumption may decrease risk of colorectal, endometrial cancers

Nut consumption may decrease risk of colorectal, endometrial cancers

Nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.

Mediterranean diet could lessen endometrial cancer risk

Mediterranean diet could lessen endometrial cancer risk

Women who followed a Mediterranean-style diet saw a significant reduction in their risk of endometrial cancer, according to a new study.

Women can reduce their risk for womb cancer by eating a Mediterranean diet

Women can reduce their risk for womb cancer by eating a Mediterranean diet

Women who eat a Mediterranean diet reduce their risk of womb cancer (endometrial cancer) by more than half.

Brachytherapy improves survival for inoperable early stage endometrial cancer

By

Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.

Oral bisphosphonate associated with decreased endometrial cancer risk

Oral bisphosphonate associated with decreased endometrial cancer risk

A reduction in endometrial cancer risk with oral bisphosphonate use in large cohort of postmenopausal women has been observed.

Soy, isoflavone consumption not associated with endometrial cancer risk

Soy, isoflavone consumption not associated with endometrial cancer risk

Soy food/isoflavone consumption is not associated with endometrial cancer risk in Japanese women.

Drinking 3 to 4 cups of coffee per day may decrease endometrial cancer risk by nearly 20%

Drinking 3 to 4 cups of coffee per day may decrease endometrial cancer risk by nearly 20%

Drinking three to four cups of coffee per day may reduce a woman's risk of developing endometrial cancer by nearly a fifth.

Metabolic syndrome linked to increased risk of endometrial cancer

Metabolic syndrome linked to increased risk of endometrial cancer

A metabolic syndrome diagnosis is linked with higher risk of endometrial cancer; excess weight likely a big factor, but other conditions also appear to play a part.

Metabolic syndrome associated with increased risk of endometrial cancer

Metabolic syndrome associated with increased risk of endometrial cancer

Whether the association with endometrial cancer was due to obesity or metabolic syndrome was unclear.

Hispanic women less likely to survive endometrial uterine cancer

By

Hispanic women in the United States were significantly less likely to survive endometrial uterine cancer than non-Hispanic white women.

Bisphosphonates linked to lower endometrial cancer risk

Bisphosphonates linked to lower endometrial cancer risk

Nitrogen-containing bisphosphonates have been associated with reduced risk of endometrial cancer, according to research.

Concurrent radiation and chemotherapy after surgery effective in high-risk endometrial cancer

By

Radiation therapy with concurrent paclitaxel chemotherapy after surgery can be effective to treat patients with high-risk endometrial cancer, according to new research.

No association found between soy food consumption and endometrial cancer risk

No association found between soy food consumption and endometrial cancer risk

By

A new study of Japanese women showed no evidence for a protective association between soy food or isoflavone intake and risk of endometrial cancer.

Soy intake has little effect on endometrial cancer risk

Soy intake has little effect on endometrial cancer risk

There is no association between soy consumption and endometrial cancer risk, according to a study published online in BJOG: An International Journal of Obstetrics & Gynaecology.

Guideline issued for postoperative radiation therapy for endometrial cancer

By

The use of adjuvant radiation therapy in the treatment of endometrial cancer is detailed in a new guideline issued by the American Society of Radiation Oncology (ASTRO).

Evidence warrants screening patients with endometrial cancer for Lynch syndrome

By

Scientific evidence is mounting that warrants screening all patients with endometrial cancer for Lynch syndrome.

Sensitizing endometrial tumors to PARP inhibitors

By

Modulating the hormonal environment in which endometrial cancers grow could make tumors significantly more sensitive to a new class of drugs known as poly(ADP-ribose) polymerase (PARP) inhibitors, according to new research.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs